PCI Biotech and MDimune Inc. announced a preclinical research collaboration that would offer several opportunities for future development.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.858 NOK | -2.21% | -2.21% | -11.31% |
1st Jan change | Capi. | |
---|---|---|
-11.31% | 66.38L | |
+16.49% | 12TCr | |
+21.73% | 12TCr | |
+23.00% | 2.66TCr | |
-21.81% | 1.99TCr | |
-16.77% | 1.63TCr | |
-18.81% | 1.55TCr | |
-44.74% | 1.55TCr | |
+62.72% | 1.48TCr | |
+3.09% | 1.37TCr |
- Stock Market
- Equities
- PCIB Stock
- News PCI Biotech Holding ASA
- PCI Biotech and MDimune Announce Research Collaboration Agreement